S&P 500   3,297.63 (+0.81%)
DOW   26,672.77 (+0.92%)
QQQ   269.41 (+1.36%)
AAPL   434.86 (+2.31%)
MSFT   214.05 (+4.41%)
FB   252.71 (-0.38%)
GOOGL   1,475.54 (-0.83%)
AMZN   3,115.77 (-1.55%)
NVDA   440.62 (+3.78%)
CGC   18.46 (+0.98%)
BABA   256.51 (+2.19%)
TSLA   1,493.05 (+4.35%)
MU   50.38 (+0.64%)
GE   6.18 (+1.81%)
AMD   77.80 (+0.48%)
T   29.55 (-0.10%)
F   6.69 (+1.21%)
ACB   10.20 (+0.10%)
GILD   71.86 (+3.35%)
NFLX   500.77 (+2.43%)
DIS   116.28 (-0.56%)
BAC   25.17 (+1.17%)
BA   162.62 (+2.92%)
S&P 500   3,297.63 (+0.81%)
DOW   26,672.77 (+0.92%)
QQQ   269.41 (+1.36%)
AAPL   434.86 (+2.31%)
MSFT   214.05 (+4.41%)
FB   252.71 (-0.38%)
GOOGL   1,475.54 (-0.83%)
AMZN   3,115.77 (-1.55%)
NVDA   440.62 (+3.78%)
CGC   18.46 (+0.98%)
BABA   256.51 (+2.19%)
TSLA   1,493.05 (+4.35%)
MU   50.38 (+0.64%)
GE   6.18 (+1.81%)
AMD   77.80 (+0.48%)
T   29.55 (-0.10%)
F   6.69 (+1.21%)
ACB   10.20 (+0.10%)
GILD   71.86 (+3.35%)
NFLX   500.77 (+2.43%)
DIS   116.28 (-0.56%)
BAC   25.17 (+1.17%)
BA   162.62 (+2.92%)
S&P 500   3,297.63 (+0.81%)
DOW   26,672.77 (+0.92%)
QQQ   269.41 (+1.36%)
AAPL   434.86 (+2.31%)
MSFT   214.05 (+4.41%)
FB   252.71 (-0.38%)
GOOGL   1,475.54 (-0.83%)
AMZN   3,115.77 (-1.55%)
NVDA   440.62 (+3.78%)
CGC   18.46 (+0.98%)
BABA   256.51 (+2.19%)
TSLA   1,493.05 (+4.35%)
MU   50.38 (+0.64%)
GE   6.18 (+1.81%)
AMD   77.80 (+0.48%)
T   29.55 (-0.10%)
F   6.69 (+1.21%)
ACB   10.20 (+0.10%)
GILD   71.86 (+3.35%)
NFLX   500.77 (+2.43%)
DIS   116.28 (-0.56%)
BAC   25.17 (+1.17%)
BA   162.62 (+2.92%)
S&P 500   3,297.63 (+0.81%)
DOW   26,672.77 (+0.92%)
QQQ   269.41 (+1.36%)
AAPL   434.86 (+2.31%)
MSFT   214.05 (+4.41%)
FB   252.71 (-0.38%)
GOOGL   1,475.54 (-0.83%)
AMZN   3,115.77 (-1.55%)
NVDA   440.62 (+3.78%)
CGC   18.46 (+0.98%)
BABA   256.51 (+2.19%)
TSLA   1,493.05 (+4.35%)
MU   50.38 (+0.64%)
GE   6.18 (+1.81%)
AMD   77.80 (+0.48%)
T   29.55 (-0.10%)
F   6.69 (+1.21%)
ACB   10.20 (+0.10%)
GILD   71.86 (+3.35%)
NFLX   500.77 (+2.43%)
DIS   116.28 (-0.56%)
BAC   25.17 (+1.17%)
BA   162.62 (+2.92%)
Log in

OTCMKTS:VYSTVystar Stock Price, Forecast & News

$0.05
0.00 (0.00 %)
(As of 08/3/2020 01:50 PM ET)
Add
Compare
Today's Range
$0.05
Now: $0.05
$0.06
50-Day Range
$0.01
MA: $0.03
$0.06
52-Week Range
$0.00
Now: $0.05
$0.07
Volume16.91 million shs
Average Volume16.73 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vystar Corporation manufactures and sells Vytex natural rubber latex (NRL) products to the manufacturers of rubber and rubber end products in the United States. The company owns a technology to produce Vytex NRL, which reduces antigenic protein in natural rubber latex products to virtually undetectable levels in liquid NRL and finished latex products. Its NRL or latex substitutes are used in a range of products, including balloons, textiles, footwear and clothing, adhesives, foams, furniture, carpets, paints, coatings, protective equipment, and sporting equipment, as well as health care products, such as condoms, surgical and exam gloves. The company was founded in 2000 and is based in Worcester, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars


Industry, Sector and Symbol

Industry Rubber & Plastics
Sub-IndustryN/A
Current SymbolOTCMKTS:VYST
CUSIP92927N106
Phone(866) 674-5238

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1
Next Earnings DateN/A
OptionableNot Optionable
$0.05
0.00 (0.00 %)
(As of 08/3/2020 01:50 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VYST News and Ratings via Email

Sign-up to receive the latest news and ratings for VYST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vystar (OTCMKTS:VYST) Frequently Asked Questions

How has Vystar's stock been impacted by COVID-19 (Coronavirus)?

Vystar's stock was trading at $0.0058 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VYST shares have increased by 762.1% and is now trading at $0.05.
View which stocks have been most impacted by Coronavirus
.

Has Vystar been receiving favorable news coverage?

Media stories about VYST stock have trended negative this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vystar earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Vystar
.

Who are some of Vystar's key competitors?

What other stocks do shareholders of Vystar own?

Who are Vystar's key executives?

Vystar's management team includes the following people:
  • Mr. Steven Rotman, Pres, CEO, CFO & Director (Age 78)
  • Dr. Ranjit K. Matthan, Director of R&D and Director (Age 77)
  • Mr. William R. Doyle, Product Devel. Consultant (Age 61)
  • Mr. Matthew P. Clark, VP of Technical Sales (Age 46)

What is Vystar's stock symbol?

Vystar trades on the OTCMKTS under the ticker symbol "VYST."

How do I buy shares of Vystar?

Shares of VYST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vystar's stock price today?

One share of VYST stock can currently be purchased for approximately $0.05.

What is Vystar's official website?

The official website for Vystar is www.vystarcorp.com.

How can I contact Vystar?

Vystar's mailing address is 2484 Briarcliff Rd NE Ste 22 Ste 159, ATLANTA, GA 30329-3011, United States. The company can be reached via phone at (866) 674-5238.

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.